5th Gene Therapy Analytical Development Europe Summit

London, UK
May 22–24, 2024

Join Genedata at the 5th GTAD Europe Summit in London, UK.

Don't miss the opportunity to talk with our colleague, Marcell Veidner about how Genedata Selector^®  enables biopharmaceutical organizations to make data-driven go/no-go decisions regarding gene therapy products safety, quality, and integrity. The platform supports biopharmaceutical companies to produce high-quality gene therapy products that meet both GMP requirements and regulatory standards, reducing both the time-to-market and development costs. By providing out-of-the-box pipelines for automated NGS data analysis, Genedata Selector empowers scientists to implement biosafety testing in-house without the need for extensive bioinformatics training.

To get more information about Genedata Selector, please contact selector@genedata.com.